U.S. News

Gilead Refiles for Approval of HIV Drug

From U.S. Centers for Disease Control and Prevention

February 11, 2011

Foster City, Calif.-based Gilead Sciences Inc. has resubmitted its application seeking Food and Drug Administration-approval of a three-in-one HIV drug. The combination includes Gilead's Truvada (emtricitabine and tenofovir) with TMC-278, an investigational drug made by Tibotec Pharmaceuticals, a unit of Johnson & Johnson. TMC-278 is a non-nucleoside reverse transcriptase inhibitor. In January, FDA said it wanted more information about TMC-278. With the refiling, FDA now has up to 60 days to perform a preliminary review of the drug cocktail and establish a target date for action.

Back to other news for February 2011

Adapted from:
San Francisco Business Times
02.10.2011; Ron Leuty

Minnesota: University Shares $10 Million in Pursuit of New Weapon Against HIV

New Combo Pill Submitted to FDA

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.

Gilead Says FDA Won't Accept Filing for AIDS Pill

More on HIV Medications

Drugs in Development: Other New Drugs

10 Questions to Ask Yourself Before You Begin HIV Treatment

Getting to Undetectable: People Living With HIV Share Their Stories

HIV Management Today: Mental Health & HIV, the Uncharted Territory

The Gay Scene: "The Biggest Suicide Cult in History"! Say What Now? A Blog Entry by Dave R.

Get TheBody.com in the Palm of Your Hand

More >>

New! TheBody.com App

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.